Leptin-induced signaling pathways in cancer cell migration and invasion
- PMID: 30877623
- DOI: 10.1007/s13402-019-00428-0
Leptin-induced signaling pathways in cancer cell migration and invasion
Abstract
Background: Increasing evidence indicates that obesity is associated with tumor development and progression. Leptin is an adipocyte-related hormone with a key role in energy metabolism and whose circulating levels are elevated in obesity. The effect of leptin on cancer progression and metastasis and its underlying mechanisms are still unclear. Leptin can impact various steps in tumor metastasis, including epithelial-mesenchymal transition, cell adhesion to the extracellular matrix (ECM), and proteolysis of ECM components. To do so, leptin binds to its receptor (OB-Rb) to activate signaling pathways and downstream effectors that participate in tumor cell invasion as well as distant metastasis.
Conclusions: In this review, we describe metastasis steps in detail and characterize metastasis-related molecules activated by leptin, which may help to develop a roadmap that guides future work. In addition, we conclude that a profound understanding of the fundamental molecular processes that contribute to leptin-induced metastasis may pave the way for the development of new prognostic molecules and appropriate approaches to the treatment of obesity-related cancers.
Keywords: Cancer; Cell invasion; Cell migration; Leptin; Metastasis; Obesity.
Similar articles
-
The potential role of leptin in tumor invasion and metastasis.Cytokine Growth Factor Rev. 2017 Dec;38:80-97. doi: 10.1016/j.cytogfr.2017.11.002. Epub 2017 Nov 11. Cytokine Growth Factor Rev. 2017. PMID: 29158066 Free PMC article. Review.
-
RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.Cell Signal. 2017 Apr;32:104-114. doi: 10.1016/j.cellsig.2017.01.020. Epub 2017 Jan 16. Cell Signal. 2017. PMID: 28104444
-
Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2.Cell Oncol (Dordr). 2017 Dec;40(6):537-547. doi: 10.1007/s13402-017-0342-8. Epub 2017 Aug 2. Cell Oncol (Dordr). 2017. PMID: 28770546
-
Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.Oncol Rep. 2012 May;27(5):1488-96. doi: 10.3892/or.2012.1670. Epub 2012 Feb 2. Oncol Rep. 2012. PMID: 22327423
-
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.Rep Prog Phys. 2019 Jun;82(6):064602. doi: 10.1088/1361-6633/ab1628. Epub 2019 Apr 4. Rep Prog Phys. 2019. PMID: 30947151 Review.
Cited by
-
Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention.Diabetes Metab Syndr Obes. 2024 Feb 16;17:809-823. doi: 10.2147/DMSO.S450321. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38380275 Free PMC article. Review.
-
Advances in the research and application of neurokinin-1 receptor antagonists.J Zhejiang Univ Sci B. 2024 Feb 15;25(2):91-105. doi: 10.1631/jzus.B2300455. J Zhejiang Univ Sci B. 2024. PMID: 38303494 Free PMC article. Review.
-
Leptin: A Heavyweight Player in Obesity-Related Cancers.Biomolecules. 2023 Jul 6;13(7):1084. doi: 10.3390/biom13071084. Biomolecules. 2023. PMID: 37509120 Free PMC article. Review.
-
Pathophysiology of obesity and its associated diseases.Acta Pharm Sin B. 2023 Jun;13(6):2403-2424. doi: 10.1016/j.apsb.2023.01.012. Epub 2023 Jan 13. Acta Pharm Sin B. 2023. PMID: 37425065 Free PMC article. Review.
-
Role of PAX2 in breast cancer verified by bioinformatics analysis and in vitro validation.Ann Transl Med. 2023 Jan 31;11(2):58. doi: 10.21037/atm-22-6360. Ann Transl Med. 2023. PMID: 36819548 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
